Search research articles
Contact Us
Filters
Showing results (671-680 of 688) with videos related to
Page
of 69
Sort By:
Journal of Medicinal Chemistry
|
April 7, 2026
Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton's Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation
Brian T Hopkins, Isaac E Marx, Harlod George Vandeveer, et al.
Acta Neuropathologica
|
March 22, 2026
Neuropathological measures of increased tau phosphorylation across the Down syndrome lifespan
Jesse R Pascual, Isabel Rivera, Halyma Nguyen, et al.
Brain : a Journal of Neurology
|
November 8, 2025
Imaging and plasma biomarkers for pathological accumulation in Down syndrome
Julie K Wisch, Ziqiao Jiao, James T Kennedy, et al.
Neurobiology of Disease
|
September 23, 2025
Regional differences in astrocytic Aquaporin-4 protein levels and distribution in aging and Alzheimer's disease in down syndrome
Cherie A Stringer, Haley K S Miyasato, Kevin A Camey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Julie K Wisch, Ziqiao Jiao, Patrick J Lao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 22, 2025
Longitudinal study of body mass index in relation to Alzheimer's disease pathology and symptomatology in Down syndrome
Victoria L Fleming, Brian C Helsel, Lauren T Ptomey, et al.
Science (New York, N.Y.)
|
May 17, 2003
The 2002 Denali fault earthquake, Alaska: a large magnitude, slip-partitioned event
Donna Eberhart-Phillips, Peter J Haeussler, Jeffrey T Freymueller, et al.
Acta Neuropathologica
|
May 15, 2026
Frequency of mixed neuropathologies in individuals with down syndrome with and without Alzheimer's dementia
Lisi Flores-Aguilar, Thomas D Zaikos, Isabel Rivera, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
Koji Shinoda, Rui Li, Ayman Rezk, et al.
JAMA Neurology
|
March 11, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
Anne H Cross, Jeffrey M Gelfand, Simon Thebault, et al.
Page
of 69
Search research articles
Search
Showing results (671-680 of 688) with videos related to
Sort By:
Page
of 69
Journal of Medicinal Chemistry
|
April 7, 2026
Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton's Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation
Brian T Hopkins, Isaac E Marx, Harlod George Vandeveer, et al.
Acta Neuropathologica
|
March 22, 2026
Neuropathological measures of increased tau phosphorylation across the Down syndrome lifespan
Jesse R Pascual, Isabel Rivera, Halyma Nguyen, et al.
Brain : a Journal of Neurology
|
November 8, 2025
Imaging and plasma biomarkers for pathological accumulation in Down syndrome
Julie K Wisch, Ziqiao Jiao, James T Kennedy, et al.
Neurobiology of Disease
|
September 23, 2025
Regional differences in astrocytic Aquaporin-4 protein levels and distribution in aging and Alzheimer's disease in down syndrome
Cherie A Stringer, Haley K S Miyasato, Kevin A Camey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Julie K Wisch, Ziqiao Jiao, Patrick J Lao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 22, 2025
Longitudinal study of body mass index in relation to Alzheimer's disease pathology and symptomatology in Down syndrome
Victoria L Fleming, Brian C Helsel, Lauren T Ptomey, et al.
Science (New York, N.Y.)
|
May 17, 2003
The 2002 Denali fault earthquake, Alaska: a large magnitude, slip-partitioned event
Donna Eberhart-Phillips, Peter J Haeussler, Jeffrey T Freymueller, et al.
Acta Neuropathologica
|
May 15, 2026
Frequency of mixed neuropathologies in individuals with down syndrome with and without Alzheimer's dementia
Lisi Flores-Aguilar, Thomas D Zaikos, Isabel Rivera, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
Koji Shinoda, Rui Li, Ayman Rezk, et al.
JAMA Neurology
|
March 11, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
Anne H Cross, Jeffrey M Gelfand, Simon Thebault, et al.
Page
of 69